X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22727) 22727
Book Review (3501) 3501
Publication (1665) 1665
Newsletter (863) 863
Book Chapter (136) 136
Conference Proceeding (100) 100
Newspaper Article (98) 98
Magazine Article (72) 72
Dissertation (46) 46
Trade Publication Article (12) 12
Web Resource (11) 11
Book / eBook (6) 6
Government Document (4) 4
Paper (4) 4
Data Set (3) 3
Transcript (2) 2
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16250) 16250
humans (15441) 15441
ribavirin (12458) 12458
antiviral agents - therapeutic use (8494) 8494
male (8472) 8472
female (8165) 8165
hepatitis c, chronic - drug therapy (7397) 7397
ribavirin - therapeutic use (7290) 7290
hepatitis c (7248) 7248
middle aged (6920) 6920
adult (6319) 6319
gastroenterology & hepatology (6022) 6022
interferon (5685) 5685
drug therapy, combination (5584) 5584
hepatitis c virus (5426) 5426
interferon-alpha - therapeutic use (5067) 5067
treatment outcome (4715) 4715
hepacivirus - genetics (4167) 4167
genotype (3710) 3710
recombinant proteins (3467) 3467
therapy (3280) 3280
infection (3235) 3235
plus ribavirin (3214) 3214
ribavirin - administration & dosage (3125) 3125
antiviral agents - administration & dosage (3114) 3114
virus-infection (3089) 3089
hepatitis (3084) 3084
hepatitis c - drug therapy (3052) 3052
aged (3048) 3048
infectious diseases (3046) 3046
polyethylene glycols - therapeutic use (2840) 2840
virology (2829) 2829
health aspects (2827) 2827
antiviral agents - adverse effects (2655) 2655
hepatitis c, chronic - virology (2464) 2464
hepacivirus - drug effects (2401) 2401
pharmacology & pharmacy (2322) 2322
biological response modifiers (2247) 2247
interferon-alpha - administration & dosage (2218) 2218
care and treatment (2208) 2208
antiviral agents (2143) 2143
ribavirin - adverse effects (2071) 2071
viral load (2051) 2051
drug therapy (1998) 1998
hcv (1978) 1978
animals (1832) 1832
interferon-alpha - adverse effects (1807) 1807
hepatitis c, chronic - complications (1781) 1781
pegylated interferon (1773) 1773
antiviral agents - pharmacology (1733) 1733
sustained virological response (1733) 1733
virus diseases (1697) 1697
liver (1694) 1694
chronic hepatitis c (1680) 1680
analysis (1667) 1667
rna, viral - blood (1606) 1606
immunology (1598) 1598
chronic hepatitis-c (1594) 1594
research (1548) 1548
cirrhosis (1529) 1529
genetic aspects (1522) 1522
risk factors (1516) 1516
combination therapy (1515) 1515
infections (1479) 1479
viruses (1478) 1478
ribavirin - pharmacology (1450) 1450
abridged index medicus (1442) 1442
retrospective studies (1410) 1410
recombinant proteins - therapeutic use (1407) 1407
virus (1386) 1386
medicine, general & internal (1331) 1331
microbiology (1286) 1286
peginterferon (1273) 1273
combination (1268) 1268
time factors (1262) 1262
polyethylene glycols - administration & dosage (1257) 1257
interferons - therapeutic use (1250) 1250
antiviral therapy (1199) 1199
peginterferon alpha-2a (1191) 1191
sofosbuvir (1164) 1164
adolescent (1159) 1159
rna (1142) 1142
hepacivirus - isolation & purification (1135) 1135
interferon-alpha (1123) 1123
initial treatment (1101) 1101
transplantation (1096) 1096
hepatitis c - virology (1089) 1089
young adult (1086) 1086
hepatitis c - complications (1080) 1080
hiv infections - complications (1072) 1072
hiv (1070) 1070
patients (1067) 1067
recurrence (1065) 1065
genotypes (1053) 1053
prospective studies (1032) 1032
fibrosis (1008) 1008
gastroenterology and hepatology (1006) 1006
telaprevir (1003) 1003
liver cirrhosis (998) 998
hepatocellular-carcinoma (988) 988
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21617) 21617
French (401) 401
Spanish (385) 385
German (303) 303
Japanese (225) 225
Korean (203) 203
Russian (188) 188
Chinese (173) 173
Polish (110) 110
Portuguese (84) 84
Hungarian (67) 67
Italian (51) 51
Czech (48) 48
Turkish (35) 35
Croatian (22) 22
Serbian (14) 14
Dutch (11) 11
Danish (8) 8
Hebrew (6) 6
Swedish (6) 6
Finnish (5) 5
Slovak (5) 5
Bosnian (3) 3
Norwegian (3) 3
Persian (3) 3
Lithuanian (2) 2
Romanian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Icelandic (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | PLUS RIBAVIRIN | ABT-450/R-OMBITASVIR | VIRUS-INFECTION | TELAPREVIR | SOFOSBUVIR | CHRONIC HEPATITIS-C | COMBINATION | TRIAL | CIRRHOSIS | BOCEPREVIR | GASTROENTEROLOGY & HEPATOLOGY | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 108 - 117
Background & Aims Interferon alfa–based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated,... 
Gastroenterology and Hepatology | Antiviral Agent | Clinical Trial | DAA | NS5B Polymerase Inhibitor | PLUS RIBAVIRIN | ANTIVIRAL THERAPY | EFFICACY | HCV GENOTYPE 1 | MULTICENTER EXPERIENCE | COMBINATION | RECIPIENTS | PEGYLATED INTERFERON | GRAFT-SURVIVAL | GASTROENTEROLOGY & HEPATOLOGY | DRUG-DRUG INTERACTIONS | Recurrence | Prospective Studies | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Viral Load | Time Factors | Ribavirin - pharmacokinetics | Female | Hepatitis C - complications | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Spain | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Virus diseases | Relapse | Liver | Transplantation | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Immunosuppressive agents | Ribavirin | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1867 - 1877
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 18, pp. 1839 - 1850
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 135, Issue 2, pp. 451 - 458
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 705 - 716
Journal Article